Abstract

Purpose of review. Reduction of child mortality is one of the Millennium Development Goals; as low-income and middle-income countries (LMICs) advance toward the achievement of this goal, initiatives aimed at reducing the burden of noncommunicable diseases, including childhood cancer, need to be developed. Recent findings. Approximately 200 000 children and adolescents are diagnosed with cancer every year worldwide; of those, 80 % live in LMICs, which account for 90 % of the deaths. Lack of quality population-based cancer registries in LMICs limits our knowledge of the epidemiology of pediatric cancer; however, available information showing variations in incidence may indicate unique interactions between environmental and genetic factors that could provide clues to cause. Outcome of children with cancer in LMICs is dictated by late presentation and underdiagnosis, high abandonment rates, high prevalence of malnutrition and other comorbidities, suboptimal supportive and palliative care, and limited access to curative therapies. Initiatives integrating program building with education of healthcare providers and research have proven to be successful in the development of regional capacity. Intensity-graduated treatments adjusted to the local capacity have been developed. Summary. Childhood cancer burden is shifted toward LMICs; global initiatives directed at pediatric cancer care and control are urgently needed. International partnerships facilitating stepwise processes that build capacity while incorporating epidemiology and health services research and implementing intensity-graduated treatments have been shown to be effective.

Highlights

  • Reduction of child mortality is one of the Millennium Development Goals; as low-income and middle-income countries (LMICs) advance toward the achievement of this goal, initiatives aimed at reducing the burden of noncommunicable diseases, including childhood cancer, need to be developed

  • 200 000 children and adolescents are diagnosed with cancer every year worldwide; of those, 80 % live in LMICs, which account for 90 % of the deaths

  • Lack of quality population-based cancer registries in LMICs limits our knowledge of the epidemiology of pediatric cancer; available information showing variations in incidence may indicate unique interactions between environmental and genetic factors that could provide clues to cause

Read more

Summary

Уважаемые коллеги!

В первом выпуске рубрики «Прогресс в детской гематологии-онкологии в XXI веке» мы приводим статью нашего коллеги и выдающегося ученого в области детской онкологии – Карлоса Родригеза-Галиндо. Данный всеобъемлющий труд рассказывает об основных проблемах на пути развития детской гематологии-онкологии в мире и в особенности в странах с низким и средним уровнем доходов, куда в последние годы не входит Российская Федерация. Описанных в статье, относится и к нашей стране. В рамках региональной деятельности Национального общества детских гематологов и онкологов по совместным проектам «Дальние регионы» и «Лечим вместе» мы стараемся реализовывать образовательный подход, о котором говорится в данной статье, но нам предстоит еще многое сделать в контексте организационных изменений в службе детской гематологии-онкологии на региональном и федеральном уровнях. Что данный обзор будет одним из элементов, который пойдет в «копилку» знаний региональных и федеральных лидеров-организаторов здравоохранения

Глобальные достижения в детской онкологии*
Global challenges in pediatric oncology
Бесплатная база данных онлайн
Продвижение национальных программ по контролю в области рака
Findings
Приоритеты Формирование команд Международное сотрудничество Рост
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.